168 related articles for article (PubMed ID: 35778569)
1. Diagnostic value of the relative enhancement ratio of the portal venous phase to unenhanced CT in the identification of lipid-poor adrenal tumors.
Jin S; Zhang H; Pan W; Yang J; Zhang B; Dong X; Li X; Wu X; Ji W
Abdom Radiol (NY); 2022 Sep; 47(9):3308-3317. PubMed ID: 35778569
[TBL] [Abstract][Full Text] [Related]
2. Relative Enhancement Ratio of Portal Venous Phase to Unenhanced CT in the Diagnosis of Lipid-poor Adrenal Adenomas.
Nagayama Y; Inoue T; Kato Y; Tanoue S; Kidoh M; Oda S; Nakaura T; Hirai T
Radiology; 2021 Nov; 301(2):360-368. PubMed ID: 34463552
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of relative wash-in ratio of adrenal lesions at early biphasic CT.
Foti G; Faccioli N; Manfredi R; Mantovani W; Mucelli RP
AJR Am J Roentgenol; 2010 Jun; 194(6):1484-91. PubMed ID: 20489087
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol.
Kamiyama T; Fukukura Y; Yoneyama T; Takumi K; Nakajo M
Radiology; 2009 Feb; 250(2):474-81. PubMed ID: 19037020
[TBL] [Abstract][Full Text] [Related]
5. Adrenal Adenomas versus Metastases: Diagnostic Performance of Dual-Energy Spectral CT Virtual Noncontrast Imaging and Iodine Maps.
Nagayama Y; Inoue T; Oda S; Tanoue S; Nakaura T; Ikeda O; Yamashita Y
Radiology; 2020 Aug; 296(2):324-332. PubMed ID: 32452733
[TBL] [Abstract][Full Text] [Related]
6. Dual Energy-Derived Metrics for Differentiating Adrenal Adenomas From Nonadenomas on Single-Phase Contrast-Enhanced CT.
Loonis AT; Yu H; Glazer DI; Bay CP; Sodickson AD
AJR Am J Roentgenol; 2023 May; 220(5):693-704. PubMed ID: 36416399
[No Abstract] [Full Text] [Related]
7. Machine learning analysis of adrenal lesions: preliminary study evaluating texture analysis in the differentiation of adrenal lesions.
Altay C; Başara Akın I; Özgül AH; Adıyaman SC; Yener AS; Seçil M
Diagn Interv Radiol; 2023 Mar; 29(2):234-243. PubMed ID: 36987841
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
Korobkin M; Brodeur FJ; Yutzy GG; Francis IR; Quint LE; Dunnick NR; Kazerooni EA
AJR Am J Roentgenol; 1996 Mar; 166(3):531-6. PubMed ID: 8623622
[TBL] [Abstract][Full Text] [Related]
9. Unenhanced Dual-Layer Spectral-Detector CT for Characterizing Indeterminate Adrenal Lesions.
Nagayama Y; Inoue T; Oda S; Tanoue S; Nakaura T; Morinaga J; Ikeda O; Hirai T
Radiology; 2021 Nov; 301(2):369-378. PubMed ID: 34427466
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of hepatic CT and chemical-shift MRI to discriminate lipid-poor adrenal adenomas from hepatocellular carcinoma metastases.
Nagayama Y; Hayashi H; Taguchi N; Yoshida R; Harai R; Kidoh M; Oda S; Nakaura T; Hirai T
Abdom Radiol (NY); 2024 May; 49(5):1626-1637. PubMed ID: 38456897
[TBL] [Abstract][Full Text] [Related]
11. Adenoma characterization: adrenal protocol with dual-energy CT.
Kim YK; Park BK; Kim CK; Park SY
Radiology; 2013 Apr; 267(1):155-63. PubMed ID: 23329655
[TBL] [Abstract][Full Text] [Related]
12. CT of hemorrhagic adrenal adenomas: radiologic-pathologic correlation.
Corwin MT; Kadivar SC; Graves CE; Kamangar E; Carney BW; Campbell MJ
Abdom Radiol (NY); 2023 Feb; 48(2):680-687. PubMed ID: 36380211
[TBL] [Abstract][Full Text] [Related]
13. Adrenal metastases: early biphasic contrast-enhanced CT findings with emphasis on differentiation from lipid-poor adrenal adenomas.
Zhu F; Zhu X; Shi H; Liu C; Xu Z; Shao M; Tian F; Wang J
Clin Radiol; 2021 Apr; 76(4):294-301. PubMed ID: 33509608
[TBL] [Abstract][Full Text] [Related]
14. Characterization of adrenal lesions using MDCT wash-out parameters: diagnostic accuracy of several combinations of intermediate and delayed phases.
Foti G; Malleo G; Faccioli N; Guerriero A; Furlani L; Carbognin G
Radiol Med; 2018 Nov; 123(11):833-840. PubMed ID: 29923085
[TBL] [Abstract][Full Text] [Related]
15. The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging.
Koo HJ; Choi HJ; Kim HJ; Kim SO; Cho KS
Eur Radiol; 2014 Jun; 24(6):1410-20. PubMed ID: 24647823
[TBL] [Abstract][Full Text] [Related]
16. [Value of single-source dual-energy CT (ssDECT) in differentiating lipid-poor adrenal adenomas from metastatic lesions].
Ju Y; Liu AL; Wang HQ; Liu YJ; Liu JH; Chen AL; Chen LH; Li Y; Han Z
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):826-832. PubMed ID: 27998440
[No Abstract] [Full Text] [Related]
17. Delayed enhanced CT of lipid-poor adrenal adenomas.
Caoili EM; Korobkin M; Francis IR; Cohan RH; Dunnick NR
AJR Am J Roentgenol; 2000 Nov; 175(5):1411-5. PubMed ID: 11044054
[TBL] [Abstract][Full Text] [Related]
18. Lipid-poor adenomas on unenhanced CT: does histogram analysis increase sensitivity compared with a mean attenuation threshold?
Ho LM; Paulson EK; Brady MJ; Wong TZ; Schindera ST
AJR Am J Roentgenol; 2008 Jul; 191(1):234-8. PubMed ID: 18562751
[TBL] [Abstract][Full Text] [Related]
19. Iodine and Fat Quantification for Differentiation of Adrenal Gland Adenomas From Metastases Using Third-Generation Dual-Source Dual-Energy Computed Tomography.
Martin SS; Weidinger S; Czwikla R; Kaltenbach B; Albrecht MH; Lenga L; Vogl TJ; Wichmann JL
Invest Radiol; 2018 Mar; 53(3):173-178. PubMed ID: 28990974
[TBL] [Abstract][Full Text] [Related]
20. Dual-energy CT in the differentiation between adrenal adenomas and metastases: Usefulness of material density maps and monochromatic images.
Cano Alonso R; Álvarez Vázquez A; Andreu Vázquez C; Thuissard Vasallo IJ; Fernández Alfonso A; Recio Rodríguez M; Martínez de Vega V
Radiologia (Engl Ed); 2023; 65(5):402-413. PubMed ID: 37758331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
